It is a digital, cloud based solution that connects all stakeholders engaged in the provision, management and monitoring of vaccines and enables the following:
The value proposition is (i) to enable data informed decision-making by Ministries of Health and nominated stakeholder groups so as to ensure that the desired COVID-19 vaccine deployment rate and population immunisation coverage is achieved (ii) the longer term strengthening/resilience of health care systems.
No; the offering is GSM network agnostic and can be deployed across third party GSM networks.
Yes, at a country level to enable Ministries of Health to procure technology (SaaS licenses), ICT and Implementation services.
The Public Sector is the focal point, as most AU Member States will be the locus of control for National vaccine provision. However, the Private Sector will invariably participate in the delivery and support of vaccines (e.g. as is the case in South Africa and what is proposed, inter alia, in Kenya). Mezzanine is comfortable to work with any stakeholder, under guidance of the Ministry.
It is focused on Africa and all its Member States.
Success in deploying any technology can be measured by acceptance and adoption of the digital tool (in the field) and the incorporation of the data it generates at programme and policy levels to inform decisions. In short, success is about effective programmes and change management. This is a relatively ‘low tech’, but a high friction requirement over a minimum 2 year term (Mezzanine recommendation). Implementation requires credible, domain expert entities – in country – that can support both the field experience and the programme and policy experience. Some of the key performance areas include, inter alia:
Mezzanine health services have previously been/are deployed in the following countries:
There are multiple ways to effect registration, including
The solution can support configurable eligibility rules set against the available data elements (mVacciNation country data model), particularly for later roll-out phases. The solution enables a centralised database management using adaptable, mixed criteria for eligibility. This process can be done in phases, if integrations require long lead-times. Initial qualification can be done using exports from these databases or similar.
Once rule sets are created, these can assist with in-time and ever evolving eligibility management.
This is an expected challenge. Our experience in the field suggests that potentially 20-30% of adult beneficiaries may lack a mobile phone (especially women). It is unknown how many of this cohort has access to a SIM. Irrespective, we consider the following potential solutions (non exhaustive):
Mezzanine does not provide any specific services to address vaccine hesitancy as part of mVacciNation. However, during the pandemic Vodacom has worked closely with governments to deliver public health messages via SMS, and in some cases set up call centres for Covid-19 information. Where there is a demand from governments, we can explore doing the same for the vaccine rollout. Mezzanine, via its MNO partners and potentially via other 3rd Parties, could support the handling of any inbound queries and outbound compliance and demand generation messaging if required2.
Mezzanine provides mVaccination on a SaaS (off the shelf) basis; the contract period is a minimum of 12 months.
Excluded (can be quoted separately):
Excluded (Implementation Partner/Client)
Yes. This is part of the country localisation effort.
Mezzanine has significant experience in deploying digital services in Africa, particularly at the junction of the first mile~last mile in Public healthcare. The following evince this claim:
Deep Insights into Pharmaceutical & Laboratory Supply Chain Context
Market validated Beneficiary Registration, Management, Scheduling and Redemption toolbox
Proven ability to manage complex, large-scale deployments within rapid timelines
Client-centric, and responsive approach to service delivery
Formal Service Levels Guarantees & Data Governance
The key risks associated with the deployment of mVacciNation into any of the AU Member States are captured below.
Delays in mVaccination “go live”
mVacciNation is a product operating in a complex adaptive industry within an ecosystem of Country, Continental and Global partners. The technology deployment is relatively quick and within the control of Mezzanine. However, the operation of the solution requires the provision of ICT and Implementation services. Further, the dependencies relating to Country level decision-making, vaccine availability, vaccine throughput and clinical support etc are not within Mezzanine control.
Countries must make an upfront commitment, including with full resource support to partner with a reputable, strong Implementation Partner. Ideally, the Implementation Partner should also establish a Country Level support mechanism that includes clinical support and is aligned to AU policies & procedures.
Country Government’s in alignment with the AU CDC commit to establishing a fully mandated, independent or autonomous mechanism that consists of recognised domain experts to execute on rapid decision-making, akin to Churchill’s “war cabinet”.
No Clinical oversight
Countries will be rolling out potentially many vaccines that may not yet have full regulatory authorisation; in addition, Vaccine Adverse Events are expected. A Clinical Advisory Board is required to support Country decision-making; this can be at a country or continental level.
mVacciNation is reliant on a functional Internet and GSM connectivity to redeem vaccine tickets (vouchers). If for whatever reason the digital technology goes offline, beneficiaries can not redeem tokens against vaccination.
All Mezzanine software solutions are provided as a Software as a Service (SaaS) contract. The mVacciNation SaaS Enterprise SLAs include SaaS and all underlining multi-tenant Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) services. AU Member States benefit from the shared services environment in terms of quality of service (SLAs), affordability, scalability and improved interoperability across applications and information across information ecosystems (refer to the note below).
The mVacciNation SLA offering to AU member states will be as a cloud hosted solution. Authorised Country specific users, mobile and web, will be enrolled against the Country account. Access rights can be configured.
The benefits of the multi-tenant cloud instance are:
Through the shared service multi-tenancy approach Mezzanine is able to offer an end-to-end service level:
Commitment to delivering on the following performance targets:
Mezzanine Ware (Pty) Ltd holds an ISO 27001:2013 certification, which is a globally trusted standard for Information Security. This certification was issued by BSI (British Standards Institute). Having an ISO 27001 certification demonstrates that the company has information security policies and controls that meet the requirements and guidelines of the standard. The certification is reviewed annually with an external surveillance audit. The certification covers the entire company and ensures that all staff members have been trained in Information Security and Risk Management, and that it is effectively applied through an Information Security Management System (ISMS).
The following rules govern the gathering and use of client data:
All the (currently authorised and approved) vaccines against SARS-CoV-2 are required to be stored within specific temperature bands and if there is transgression outside of these bands there is a risk of physical corruption: this has negative clinical outcomes. In addition, cost management is a critical requirement: these vaccines are expensive and – in fragile, weakened supply chains and challenging operational conditions, the risk of waste is high.
It is therefore desirable to be able to monitor the vaccine cold chain. However, the locus of control may be vested more proximally, i.e. at the level of the Vaccine Manufacturer or Logistics Partner (often at the behest of the purchaser, e.g. Covax, Government, Insurer etc) of which there are many. As noted, there are at least 12 vaccines available in the market. Mezzanine can support a cold chain monitoring capability whereby mVacciNation users at VSP’s can capture fridge or container temperature and enter the data into the application. Mezzanine will not directly provide an IoT based cold chain sensor, but subject to a formal request from a client with an existing IoT solution in place (or envisaged), could integrate with such a solution through API; the data can then be displayed on the mVacciNation application.
1 The Mezzanine digital solutions can be provided by any GSM mobile network operator in Africa.
2 The system does provide scheduled messaging wrt upcoming vaccine events per person.